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Abstract
In recent times, the Mediterranean diet plans are very popular because it has a
lot of advantage in protecting from chronic health problems. Nuts are the integral
part of the Mediterranean diet and advised to be incorporated in diet for health
benefits. Both tree nuts and pea nut are good source of unsaturated fatty acids,
soluble and insoluble fibers, good quantity of vitamins, minerals and phytochemi-
cals with recognized benefits to human health. Due to life style disorders many
chronic diseases are increasing in human beings. There are many epidemiological
studies and research conducted on the relationship between consumption of nuts
and chronic disease risks. This book chapter elaborately discusses about the nutri-
tional composition of the nuts and their effect on cardiovascular disease, obesity,
diabetes and cancer.
Keywords: nuts, chemical composition, cardiovascular disease, obesity, diabetes,
cancer
1. Introduction
Nuts are excellent source of nutrients and bio active compounds. It is consumed
by majority of the populations of the world in some form or other depending upon
the availability in the geographical area. Nuts can be divided in to two types such as
tree nuts and legumes. The important tree nuts are viz., almonds, walnuts, pista-
chios, cashew nuts, Brazil nuts, hazelnuts, macadamia, and pine nut. Peanut is a
legume commonly consumed as roasted or as pea nut butter. Pea nut is more
economical than other nuts and popularly called as ‘poor man’s almond’. These nuts
due to their unique nutritional properties are very much appreciated in vegan diets,
gluten free diets and paleo diets [1]. Nut consumption and associated health bene-
fits gained much interest in recent times and even considered as alternative to milk
and meat [2, 3]. Nuts are the part of traditional Mediterranean diet and now the
nutrition research community advocates its consumption in a regular basis [4].
There is a gradual increase in non-communicable diseases (NCDs) such as car-
diovascular, obesity, diabetes and cancer in the population. The major reason for
the NCDs are basically due to life style disorders, poor feeding habit, work related
stress, and less physical activity. Cardiovascular diseases (CVDs) are a leading cause
of mortality globally and in 2010 around 13 million people died due to heart related
diseases [5]. Obesity constitutes a worldwide epidemic and is the major cause of
type 2 diabetes mellitus, hypertension, dyslipidemia, cardiovascular disease,
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non-alcoholic fatty liver disease, reproductive dysfunction, respiratory abnormali-
ties and psychiatric conditions [6]. According to the International Diabetes Federa-
tion (IDF) data there are 382 million diabetic people worldwide in 2013, and by
2035 the number will grow to 592 million. Diabetes brings huge economic burden to
the individuals, family as well as the health care system of a country. Similarly, as
per WHO reports the global cancer burden is estimated to have risen to 18.1 million
new cases and 9.6 million deaths in 2018. These diseases are the serious concerns in
the society for future developments and progress.
Nut consumption has proven role in reducing cardiovascular diseases [7], obe-
sity [8], hypertension [9], diabetes mellitus [10], and cancer [11]. Dietary nuts
reduces the mediators of chronic diseases such as oxidative stress, inflammation,
visceral adiposity, hyperglycemia, insulin resistance, endothelial dysfunction, and
metabolic syndrome with the unique bioactive compounds what they possess [12].
This chapter will review the nutritional composition of tree nuts and pea nut.
The consumption of nut and health aspects related to cardiovascular disease,
obesity, diabetes and cancer are also the major highlights of this chapter.
2. Nutrient composition of nuts
Nuts are good source of nutrients such as fats with good quantity of mono
unsaturated fatty acids (MUFA) and poly unsaturated fatty acids (PUFA), soluble
and insoluble fibers, vitamins E and K, folate, thiamine and minerals such as mag-
nesium, copper, potassium, and selenium [13]. The phytochemicals such as phenolic
compounds, zanthophyll carotenoids, alkaloids, and phytosterols compounds, with
recognized benefits to human health are also the major constituents of nuts.
Nuts are very good source of fats after vegetable oil seeds and are calorie-dense
(500–700 kcal/100 g edible portion). The lipid quantity in the nuts varies in a
range of 40 to 75% (Table 1). Typically, walnut, macadamia, pine nut, Brazil nut
and pecans contain higher lipid (70%) as compared to cashew, almond, pistachio
and hazelnut which contains lipid between 45 and 62%. The lipid content of all the
nuts varies according to the agro-climatic condition, maturity of kernels and varie-
ties. Barreca et al. [14] observed lipid content 42.4–56% in 19 varieties of almond
grown in different agro-climatic conditions. Similarly, Venkatachalam et al. [15]
indicated a range in the lipid content 67–78.1% for 27 pecan cultivars grown in
different regions of the United States. The availability of phytosterols and
sphingolipids are also common in tree nuts. The sterol content in tree nuts ranges
from 0.16 (pine nut) to 0.28 g/100 g (pecans) of the oil content. In the phospholipid
fraction, all most all the tree nuts contain more amount of phosphotidylcholine in a
range of 0.37 g/100 g oil (pine nut) to 0.78 g/100 g oil (Brazil nut) followed by
phosphotididylserine in range of 0.32 g/100 g oil (almond and Brazil nut) to 0.59 g/
100 g oil (pistachio) and phosphatidylinositol in a range of 0.08 g/100 g oil (hazel
nut) to 0.31 g/100 g/100 g oil (walnut).
All most all the edible nuts contain good amount mono unsaturated fatty acids
(MUFA) followed by poly unsaturated fatty acids (PUFAs) (Table 2). The MUFA
content of nuts are basically in the form of oleic acid (18:1 n-9). The oleic acid
content of almond varies in a range of 50 to 80% of the total MUFA content.
Similarly, the oleic acid is 76 to 86% of the total MUFA content of hazelnut [16].
The PUFA content of almond is in the form of linoleic acid (LA, 18:2 n-6) which is
around 24% of the total fat content. Nuts basically contain LA and alpha linolenic
acid (ALA, 18:3 n-3) as PUFAs. However, LA is the dominant PUFA in nuts.
Micronutrients such as vitamins and minerals are the major groups of nutrients
that the body needs for several physiological functions. Nuts such as almond,
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cashew nuts, pistachios, walnut and peanuts are very good source of B-vitamins,
folate and vitamin E (Table 3). Nuts are also rich source of minerals such as
magnesium and potassium (Table 4). Selenium is found particularly in Brazil nuts
in greater concentrations.
There are varieties of phytochemicals present in nuts (Table 5) and they are well
known in health and disease of humans [20]. Tree nut phytochemicals such as total
phenols, flavonoids, proantocyanidins (PAC), stilbenes, phytosterols, carotenoids
have been associated with many bioactivities such as antioxidant, antiviral,
antiproliferative, hypocholesterolemic, and anti-inflammatory actions [21, 22]. The
poly phenolic compounds are the major phytochemical class. All most all the tree
nut are very good source of total phenolic compounds. However, walnuts and
pecans are considered as the richest source of the total phenolic compounds
Nuts Oil content TG Sterol Sterol ester PS PI PC PA SL Energy
kcal
Almonds 53 98 0.25 0.05 0.32 0.17 0.56 ND 0.63 581
Walnuts 72.5 97.1 0.28 0.09 0.46 0.31 0.52 ND 0.68 618
Pistachio 54.1 95.8 0.21 0.03 0.59 0.28 0.68 ND 0.82 557
Cashew 45 96 — — — — 0.54 — — 553
Brazil nuts 68.9 96.6 0.19 0.05 0.32 0.10 0.78 ND 0.91 656
Pine nut 75.1 97.1 0.16 0.05 0.33 0.19 0.37 ND 0.57 629
Pecans 73.4 96.3 0.28 0.07 0.47 0.18 0.52 ND 0.55 691
Macadamia nuts 71.0 — — — — — — — — 718
Hazelnuts 61.9 97.6 0.22 0.04 0.36 0.08 0.48 0.05 0.32 629
TG, triacylglycerol.
Source: Miraliakbari and Shahidi [17]; US Department of Agriculture Nutrient Data Base at http://www.nal.usda.g
ov/fnic/cgi-bin/nut_search.pl
Note: The oils of tree nuts were extracted using chloroform/methanol system; ND, Not Detected.
Table 1.
Lipid Classes (g/100 g oil) and energy content of nuts.
Nuts Total fat SFA MUFA PUFA 18:2n-6 18:3n-3
Almonds 50.6 3.9 32.2 12.2 12.2 0.00
Walnuts 65.2 6.1 8.9 47.2 38.1 9.08
Pistachio 44.4 5.4 23.3 13.5 13.2 0.25
Cashew 46.4 9.2 27.3 7.8 7.7 0.15
Brazil nuts 66.4 15.1 24.5 20.6 20.5 0.05
Pine nut 68.4 4.9 18.8 34.1 33.2 0.16
Pecans 72.0 6.2 40.8 21.6 20.6 1.00
Macadamia nuts 75.8 12.1 58.9 1.5 1.3 0.21
Hazelnuts 60.8 4.5 45.7 7.9 7.8 0.09
Peanuts 49.2 6.8 24.4 15.6 15.6 0.00
Source: Kim et al. [18], modified.
Table 2.
Fatty acid profile of nuts (g/100 g).
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Almond 0.2 0.8 3.9 0.3 0.1 0.0001 0.05 0.0 25.9 0.0 0.0
Walnut 0.3 0.2 1.1 0.6 0.5 0.0005 0.098 1.3 13.0 0.001 0.0003
Pistachio 0.9 0.2 1.3 0.5 1.7 0.0017 0.051 5.0 2.3 0.028 0.0
Cashew nut 0.4 0.1 1.1 0.9 0.4 0.0004 0.025 0.5 0.9 0.0 0.0341
Brazil nut 0.1 0.04 0.3 0.2 0.1 0.0001 0.022 0.7 5.7 0.0 0.0
Hazelnuts 0.6 0.1 1.8 0.9 0.6 0.0006 0.133 6.3 15.0 0.001 0.0142
Pine nut 0.4 0.2 4.4 0.3 0.1 0.0001 0.034 0.8 9.3 0.0 0.0539
Pecan 0.7 0.1 1.2 0.9 0.2 0.0002 0.022 1.1 1.4 0.0 0.0035
Macademia 1.2 0.2 2.5 0.8 0.3 0.0003 0.011 1.2 0.5 0.0 0.0
Peanuts 0.18 0.04 5.75 0.59 0.11 - 0.062 0 0 0 0.00295
Source: Sathe et al. [19], modified.
Table 3.





























containing around 1600 mg GAE/100 g. Almond, Brazil nuts, cashews, macadamias
and pine nuts contains almost similar amount of total phenol between 200 to
300 mg GAE/100 g. Flavonoids are a subclass of phenolics and mainly are available
in three forms such as flavan-3-ols, flavonols and anthocyanins. In tree nut, the
flavonoid content varies from 0.03 mg/100 g in pine nuts to 2700 mg/100 g in
pecans. Hazel nuts and pecans are the major source of Proanthocyanidins (PAC)
and contains around 500 mg/100 g. Stilbenes are the plant secondary metabolites
derived from the phenylpropanoid pathway [23]. Among nuts, pistachio
(803.22 μg/100 g) is the only nut has been reported to contain stilbenes. The sterol
content in tree nuts ranges between 105 to 233 mg/100 g. Carotenoids are the color
pigments which is ubiquitous in the plant kingdom. There are more than 750
carotenoids have been reported in nature, out of which 500 have been properly
characterized. Brazil nut and Macadamias are reported to have no carotenoids
however; pistachios are very rich in carotenoid content (22,832 μg/100 g). Cashew
nut kernel contains carotenoids such asβ carotene (9.57 μg/100 g), lutein (30.29 μg/
100 g) and zeaxanthin (0.56 μg/100 g) [24]. Hazel nut contains appreciable level of
carotenoids (106 μg/100 g). Carotenoid content in the hazelnut oil was estimated as
5.51 mg/kg oil while lutein and zeaxanthin were determined as main carotenoids
with the concentration of 0.19 and 0.85 mg/kg oil, respectively [25]. Alkaloids are
widely distributed and occurring in approximately 20% of plant species. Alkaloids
are not common in nuts only negligible amount was detected in walnuts. Tree nuts
contain a significant amount of phytates from 100 to 2500 mg/100 g. Almonds have
the highest reported phytate content, while pine nuts and Brazil nuts having the
lowest content.
3. Nut consumption and relationship between disease conditions
3.1 Almond
Almonds are rich in macro and micro nutrients and upon consumption in
adequate quantity impart a lot of health benefits. Traditionally, the ancient Greeks,
Persians, Chinese and Indians use almonds for medical purposes as a health-
promoting food [26]. There are also several epidemiological studies and clinical trials
Nuts (mg/100 g) Calcium Magnesium Sodium Potassium Copper Iron Zinc Selenium
Almonds 248 275 1 728 1.03 3.71 3.12 0.004
Walnuts 98 158 2 441 1585 2.91 3.09 0.005
Pistachio 107 121 1 1025 1.3 3.92 2.2 0.007
Cashew 37 292 12 660 2195 6.68 5.78 0.019
Brazil nut 160 376 3 659 1.74 2.43 4.06 1.917
Hazelnut 114 163 0 680 1725 4.7 2.45 0.002
Pine nut 16 251 2 597 1.32 5.53 6.45 0.0007
Pecans 70 121 0 410 1.2 2.53 4.53 0.004
Macadamia 85 130 5 368 0.75 3.69 1.3 0.004
Peanut 92 168 18 705 1.14 4.58 3.27 0.007
Source: United States Department of Agriculture Nutrient Database for Standard Reference.
Table 4.
Mineral composition of nuts.
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Almond 261 25.01 184.10 ND 192.37 0.002 ND 2542.11
Walnuts 1602 0.54 67.25 ND 197.89 0.021 0.0004 2070.00
Pistachios 703 136.45 252.71 0.803 189.43 22.83 ND 1562.50
Cashews 242 1.12 8.70 ND 154.00 0.031 ND 697.73
Brazil nuts 197 0.85 0–10 ND 160.19 — ND 190.00
Hazelnuts 447 13.21 500.66 ND 132.47 0.106 ND 1285.00
Macadamias 233 137.9 0–10 ND 105.70 ND ND 470.85
Pecans 1588 2713.49 494.05 ND 233.52 0.055 ND 851.60
Pine nuts 206 0.03 0–1 ND 190.75 0.026 ND 200.00
Source: Kim et al. [18].
Table 5.





























which reports positive effects of nut consumption against a different diseases condi-
tions like cardiovascular conditions, inflammation and oxidative stress, obesity,
hypertension, diabetes mellitus and metabolic syndrome [14]. The consumption of
almond and relationship between different disease conditions is presented inTable 6.
3.1.1 Almond and cardiovascular disease
The role of dietary almonds against cardiovascular disease (CVD) has been
shown in several studies. The high carbohydrate or saturated fatty acid diet is often
associated with impaired glucose and lipid homeostasis which alters blood lipid
profile in terms of elevated low density lipoprotein cholesterol (LDL-C), total
cholesterol, apolipoprotein B (Apo B), and increases body weight which leads to
cardiovascular risks. A recent study conducted by Wang et al. [27] reported that
42.5 g almond consumption per day changes LDL-C which is also cost effective to
prevent cardiovascular disease in the short term and potentially in the long term.
Furthermore, studies conducted by Gulati et al.[28] and Jalali-Khanabadi [29]
reported that dietary almond can improve blood lipid profile by lowering total
cholesterol (TC) and triglyceride, respectively in cardiovascular patients. In addi-
tion to their cholesterol-lowering effects, the ability of almonds to minimize the risk
of heart disease may also be attributed to the antioxidant activity of vitamin E found
in them. A meta-analysis of randomized controlled trial conducted by Lee-Bravatti
et al. [30] also found that >42.5 g daily consumption of almond reduced TC, LDL
cholesterol, and also significantly decreased other CVD risk factors such as body
weight. Almond consumption, other than cholesterol reduction also associated with
control of hyperlipidemia, inflammation, blood pressure, blood glucose and insulin
concentrations, metabolic syndrome, and body weight/fat/composition which also
plays key roles in managing cardiovascular risk factors [31]. The lower blood HDL-
C is the marker of cardiovascular risk [32]. Drug therapies to increase the HDL-C
level are not very much successful. Some combination of medicine such as high
doses of niacin, fibric acid or bile acid sequestrants can improve HDL-C minimally
[33]. According to the Indian Heart Association 2015, risk of heart disease comes to
half with every 10 fold increase in HDL-C [34].
The phytochemicals such as phytates and phenolics compounds in almonds
confers antioxidant, anti-inflammatory and lipid-lowering properties [35]. Almond
also contains good quantity of magnesium and potassium. Magnesium deficiency is
not only associated with heart disease, but also the lack of adequate magnesium
causes free radical damage to the heart [36]. Potassium is an effective electrolyte
necessary to maintain normal blood pressure.
3.1.2 Almond and obesity
Obesity is a very serious problem in the affluent nations which is also the basic
reason of type 2 diabetes (T2D). There are studies which demonstrate the role of
almond consumption on overweight and obesity in humans. A 24 week clinical trial
was conducted with 65 overweight and obese (body mass index (BMI): 27–55 kg/m2)
adults of age group between 27 to 79 y [37]. In the weight reduction program, the
subjects were received almond enriched and complex carbohydrate enriched low
calorie diet (LCD) with similar protein and calories. The main outcome of the study
was based on the anthropometric, body composition andmetabolic parameters which
showed that almond-LCD group experienced a sustained and greater weight reduc-
tion than the complex carbohydrate fed group. The authors concluded that the results
could be due to high MUFA content in almonds which have high oxidation rate than
get stored as fat. In another 12 week clinical trial with 86 healthy subjects with a BMI
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25 to 40 kg/m2 when treated in two diet intervention groups: an almond-enriched
hypocaloric diet (AED, 15% of total kcal from almonds) and a nut-free hypocaloric
diet (NFD) for 12 weeks showed AED followed group had significant weight loss with
reduced truncal fat mass. Similarly, the authors concluded that the results might be
due to the unsaturated fatty content in almonds which is more oxidation prone than
storage [38]. A study conducted by Foster et al. [39] on 123 overweight and obese
adults found that a daily dose of 56 g almond for 6 months is effective in body weight
loss. Taking the above results in to consideration it is understood that the MUFA,
fiber and protein of almond have a satiating effect and benefit individuals during
weight loss program.
3.1.3 Almond and diabetes
The role of almond supplementation in glucose homeostasis has been studied by
several researchers [28, 40]. In 2017, Gulati and colleagues [28] reported the health
benefits of almond in terms of measures of glycemia through the assessment of
glycosylated hemoglobin (HbA1c) in the type 2 diabetic (T2D) patients when pro-
vided 20% of the total energy intake for 24 weeks along with diet and physical
activity counseling. The HbA1c levels in subjects after almond supplementation
declined significantly compared with their levels on the control diet which is clini-
cally accepted as the indicator of reduction in the diabetic complications. Overall,
the study suggested that dietary almond controls glycemic condition through
insulin management rather than in reduction of glucose absorption or increased
clearance. Similarly, Mori and colleagues [41] reported that almond consumption
Design and study
population
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Effect of almond consumption on different disease conditions.
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improved the metabolic profile by decreasing blood glucose concentrations when
included in the breakfast meal of 14 impaired glucose tolerant (IGT) adults. It is
suggested that the high content of fiber, high unsaturated fatty acid and low carbo-
hydrate which makes almond as low glycemic index food played a role in the
reduction of glucose. Under nutrition therapy Chen et al. [42] made 40 T2D
patients receive almond for 12 weeks after a 2 weeks run in period among 27 of 33
patients with the baseline HbA1c ≤8, almond receiving groups decreased post-
interventional fasting serum glucose and HbA1c by 5.9% and 3.0% as compared to
that of control, respectively. It is concluded from the study that almonds incorpo-
rated into healthful diets can improve glycemic status in diabetic patients with a
better glycemic control. Many clinical interventions suggested that dietary almond
through multiple mechanisms of actions, i.e., reducing glycemic index value of co-
consumed food, increasing insulin secretion, and alleviating insulin resistance con-
trols diabetes [40, 43]. It is also suggested that the polyphenols mainly flavonoids
present in almond also controls blood glucose levels by the action of inhibiting
amylase which is a carbohydrate digestive enzyme [40, 44].
3.1.4 Almond and cancer
In 2018, Lee and colleagues [45] conducted a case study among 923 colorectal
cancer patients and 1846 controls recruited from the National Cancer Center in
Korea. They collected the dietary intake information of food items including nuts
such as peanuts, pine nuts, and almonds (as 1 food item). The results of the study
showed that high consumption of nuts (>45 g/week, in three servings) was strongly
associated with reduced risk of colorectal cancer. Authors concluded that the rela-
tionship between nut consumption and reduction of colorectal cancer risk could be
due to the presence of fiber, resveratrol, selenium, flavonoids (quercetin), polyphe-
nols (ellagic acid), and folic acid. These bioactive compounds have strong antioxidant
properties which regulate cell proliferation, reduce DNA damage, inflammatory
response and immunological activity as indicated by Gonzalez and Salas-Salvado
[46]. The triterpenoids present in almond, including betulinic, oleanolic, and ursolic
acids, have also been reported earlier as antitumor agents [47, 48]. There are studies
which depicts about the link between the consumption of roasted almond and devel-
opment human cancer because of the presence of acrylamide in it. Almonds contain
free asparagine and reducing sugars and acrylamide is formed when undergo roasting
above 154°C temperature [49]. Acrylamide can be found in roasted almonds, but is
not found in raw almonds. As per National Health and Nutrition Examination Survey
(NHANES) (2001–2010), daily almond consumption for a habitual American con-
sumer is 29.5 g [50]. A consumer of body weight of 65 kg the daily acrylamide
exposure from almonds would be 0.08 μg/kg body weight. The unroasted almond
consumption is more a common practice therefore; the actual acrylamide exposure
from almonds would be lower. Anticancer property of almond and its extracts has
been also been reported. Davis and Iwahashi [51] reported that whole almond and
almond fractions can reduce aberrant crypt foci (ACF) in a rat model of colon
carcinogenesis. According to Heasman andMellentin [52] the anticancer properties of
almond is mainly attributed to the phytochemicals such as, quercetin and kaempferol,
which suppresses lung and prostate tumor cell growth. Almond consumption and the
overall health benefits are presented in Figure 1.
3.2 Walnuts
Walnut is one of the world’s most popular temperate grown nuts. Walnut kernel
is a rich source of proteins, fats, minerals, vitamins, and polyphenols that render the
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fruit indispensable for human nutrition. These also have a good source of flavo-
noids, sterols, pectic compounds and phenolic acids. Worldwide 3.7 tonnes of
walnut is produced per year and china contributes approximately 50 per cent of the
total world walnut production (atlasbig.com/en-in/countries-by-walnut-
production). The consumption of walnut and relationship between different disease
conditions is presented in Table 7.
3.2.1 Walnut and cardiovascular disease
Walnuts differ from other nuts in terms high LA and ALA content which has
known anti atherogenic properties [53]. It is also recommended that 84 g of walnut
on a daily basis for four weeks has a potential to decrease serum levels of total
cholesterol by 12% [54]. The beneficial effect of walnut consumption in reducing
the risk of CVD is not limited to reducing blood cholesterol level only but also
attributed to the lowering LDL-C, vascular inflammation, improving endothelial
dysfunction and enhancing antioxidant activity [55–57]. The cholesterol lowering
effect of walnut could be due to the presence of phytosterols in it. According to
Gylling et al. [58] intake of phytosterols (2 g/day) is associated with a significant
reduction (8–10%) in LDL-cholesterol because phytosterol mostly interfere in the
intestinal absorption of cholesterol. In 2014, Wu and colleagues [59] assessed the
effect of walnuts on lipid and glucose metabolism, adipokines, inflammation and
endothelial function in 40 healthy subjects, 10 men and 30 postmenopausal women
≥50 years old with BMI 24.9  0.6 kg/m2. The subjects first received a walnut
enriched (43 g/d) and then a Western-type (control) diet or vice-versa, with each
lasting 8 weeks and separated by a 2-week wash-out. The study reported that walnut
diet significantly reduced non-HDL cholesterol (walnut vs. control: 10  3 vs.
3  2 mg/dL; p = 0.025) and apolipoprotein-B (5.0  1.3 vs. 0.2  1.1 mg/dL;
p = 0.009) in comparison to control diet after adjusting for age, gender, BMI and diet
sequence. Total cholesterol showed a trend toward reduction. However, fasting
adipokines, C-reactive protein, biomarkers of endothelial dysfunction, postprandial
Figure 1.
Almond consumption and health benefits.
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Design and study population Intervention Duration Main outcomes Reference
Cardiovascular disease




4 weeks Reduced total cholesterol,
lowered LDL-C/HDL-C ratio
[54]




varied from 28 g/
day to 78 g/day
3–
6 weeks
Reduced the TC, LDL-C, and
HDL-C values. Decreased
ratios of TC:HDL-C and LDL-









2–6 weeks Improved flow mediated
dilation and biochemically by
sVCAM (soluble vascular cell
adhesion molecules)
[57]
A randomized cross over
study (40 subjects)













Weight loss, favorable effects














controlled study (15 obese
subjects)












Reduced risk of diabetes,
reduced blood glucose and
HbA1c
[66]
A randomized control clinical
trial (100 patients)
Walnut oil 15 g/
day
3 months Decreased HbA1c level,
reduced fasting blood sugar
[69]
Diabetic male rats (200 g) Walnut oil gavage
with β-
sitosterol0.5 ml/kg










accumulation of cells in G0/
G1 phase. Down regulated
NFkB expression
[78]
Effect of walnut methanolic
extracts on human renal
cancer cell lines A-498 and





Inhibited growth of human
kidney and colon cancer cells
[79]
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[81]
Table 7.
Effect of walnut consumption on different disease conditions.
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lipid and glucose metabolism and endothelial function were unaffected. It was con-
cluded from the study that daily consumption of 43 g of walnuts for 8 weeks could be
beneficial for the reduction of non-HDL-cholesterol and apolipoprotein-B, beneficial
in lowering CHD risk. It is suggested that the increased PUFA intake through walnut
could be responsible for the lowered cholesterol in the subjects. Walnut not only a
good source of PUFA but also contains a lower ratio n6/n3 ratio. It is suggested that
the lower n-6/n-3 ratio is desirable in reducing the risk of many of the chronic
diseases including lowering blood cholesterol, reducing vascular inflammation and
improving endothelial function [60].
3.2.2 Walnut and obesity
Better weight management and less adiposity can be maintained with regular
nut consumption. Rock and colleagues [61] conducted a study where overweight
and obese men and women (n = 100) were randomly assigned to a standard reduced
energy- density diet or a walnut-enriched (15% of energy) reduced-energy diet in
the context of a behavioral weight loss intervention. Both study groups reduced
weight, body mass index and waist circumference. Change in weight was
9.4  0.9% vs. 8.9  0.7% for the standard vs. walnut-enriched diet groups,
respectively. The results of the study demonstrated that a walnut-enriched reduced-
energy diet can promote weight loss that is comparable to a standard reduced-
energy-density diet in the context of a behavioral weight loss intervention. It is
suggested that despite walnut is very high in energy density, but when consumed as
a component of a reduced-energy diet the total energy intake get reduced and also
give a satiety response. The study conducted by Katz et al. [62] on effects of walnuts
on endothelial function in overweight adults with visceral obesity found that daily
ingestion of 56 g of walnuts with ad libitum diet in comparison ad libitum diet
without walnut did not lead to weight gain however, improved endothelial func-
tion. Adiponectin is a peptide secreted from adipocytes, whose low concentration is
an indicator of overweight, visceral fat accumulations and related diseases such as
insulin resistance/T2D and cardiovascular disease [63]. The production of
adiponectin and its role is presented in Figure 2. Cardona-Alvarado et al. [64]
found that adiponectin concentration increased by 30% in obese subjects
supplemented with a daily intake of approximately 15 g of walnuts. Similarly,
Aronis et al. [65] reported that after short-term (four days) consumption of 48 g/d
walnut, 6.4% adiponectin increased in the circulation. The results suggested that the
improvement observed in the metabolic state may be due to the activation of
peroxisome proliferator-activated receptor alpha (PPARγ) and adiponectin expres-
sion, promoted by the increase in circulating lipocalin2 (Lcn2) concentrations
which is a novel regulator of brown adipose tissue.
3.2.3 Walnut and diabetes
Arab and colleagues [66] examined the associations between walnut consump-
tion and diabetes risk using data from the National Health and Nutrition Examina-
tion Survey. Diabetes status or risk was assessed on self-report, medication use,
fasting plasma glucose levels, and haemoglobinA1c (HbA1c) levels. The results
demonstrated that walnut consumers had lower risk for diabetes compared with
non-nut consumers and prevalence of diabetes dropped 47%. It is suggested from
the study that walnut possibly impact hunger. The decreased feelings of hunger and
appetite and increased activation of the right insula indirectly reduces risk of dia-
betes. In the diet of diabetic patients, carbohydrate is replaced with MUFAs and
PUFAs under therapeutic strategy [67]. The intake of MUFAs by diabetic patients
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has also been seen with elevated high density lipoprotein (HDL)-cholesterol levels
and improved blood sugar changes [68]. In this regard, Nezhad et al. [69] reported
that consumption of walnut oil (15 g/day for three months) can improve blood
glucose level. It is also suggested that oils containing PUFA could exert their
antidiabetic effect by reducing resistance and enhancing sensitivity to insulin via
the mechanism of over expression of glucose transporter GLUT4 and insulin recep-
tors on the adipocyte membrane [70]. A study conducted by Ghorbani et al. [71]
found that walnut oil led to reduction in blood glucose, cholesterol, triglyceride,
ASP, ALT, ALP, and bilirubin in diabetic rat. It is suggested that the better blood
profile was primary because of the β-sitosterol in the walnut oil. β-Sitosterol is
considered as an important potential factor in diabetes mellitus due to its effect on
regulation of glucose adsorption, adipogenesis, and lipolysis in adipocytes. It is also
presumed that like insulin, β-sitosterol down regulates GLUT4 expression however,
not fully confirmed yet [72]. Recent studies have reported that the composition and
the balance of gut microbiota are involved in the obesity and obesity-related com-
plications such as nonalcoholic fatty liver disease (NAFLD), insulin resistance and
T2D [73]. In this regard, Li et al. [74] observed that polyphenol rich walnut meal
(WMP) impeded the changes of intestinal flora in feces of rats, the gut microbiota
mainly included Firmicutes, Bacteroidetes, and Proteobacteria, the symbol of
healthy gut micro biota composition. This is the indication of promising effects of
WMP on T2DM through the change in gut microbiota composition. Authors of the
study highlighted that WMP decreased the levels of TNF-α and IL-6 in serum. TNF-
Figure 2.
Walnut intake increases circulating adiponectin levels.
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α is the first pro-inflammatory cytokine recognized for its involvement in patho-
genesis of insulin resistance and T2DM. TNF-α reduces the expression of insulin-
regulated glucose transporter type 4 (GLUT4) and increases the diabetic risk [75].
3.2.4 Walnut and cancer
There are several studies which highlights the anticancer properties of walnuts
in mice. Hardman [76] summarized the potential of walnut in cancer prevention
and treatment in mice. The points what he put forth was as follows: (1) the walnut-
containing diet inhibited the growth rate of human breast cancers implanted in
nude mice by 80%, (2) the walnut-containing diet reduced the number of mam-
mary gland tumors by 60% in a transgenic mouse model, (3) the reduction in
mammary gland tumors was greater with whole walnuts than with a diet containing
the same amount of n-3 fatty acids, supporting the idea that multiple components in
walnuts additively or synergistically contribute to cancer suppression and (4) wal-
nuts slowed the growth of prostate, colon, and renal cancers by anti-proliferative
and antiangiogenic mechanisms. The author explained that the n-3 fatty acids,
tocopherols, b-sitosterol, and pedunculagin, present in walnuts all have cancer-
prevention properties. Induja et al. [77] reported the cytotoxic effects of walnut oil
on oral cancer cell line by DNA fragmentation. They suggested that other than
perfect balance of n-6 and n-3 fatty acids, the walnut residue is rich in protein with
anticancer peptides. In 2018, Batirel and colleagues [78] investigated the effect of
walnut oil on tumor growth and metastatic potential in esophageal cancer cells. The
results of the study confirmed that 20 mg/mL walnut oil reduced cell viability of
esophageal cancer cells by50% when compared with control. Walnut oil exhibited
anti-carcinogenic effect by inducing necrosis and cell cycle arrest at the G0/G1
phase. It down regulated the NFkB pathway. It is suggested from the study that
walnut oil, and walnut consumption, may have beneficial effects in esophageal
cancer in humans. Similarly, the anti-carcinogenic effect of walnut extract has been
seen due to the antioxidant and anti-proliferative activity in many different cell
lines such as MCF-7 (estrogen receptor positive breast adenocarcinoma), HepG-2
(liver), WRL-68 (liver), A-498 (renal), 769-P (renal), KB (oral and mouth), and
Caco2 (colon) [79, 80]. In another study, walnut phenolic extract (WPE) and its
bioactive compounds suppressed colon cancer cell growth by regulating colon can-
cer stem cells (CSC) [81]. This study evaluated the anti-CSCs potential of walnut
phenolic extract (WPE) and its bioactive compounds, including (+)-catechin,
chlorogenic acid, ellagic acid, and gallic acid. WPE and its bioactive compounds to
mediate an inhibition of colon CSCs by inducing cell differentiation, down-
regulation in the expression of the CSC markers, CD133, CD44, DLK1, Notch1, and
β-catenin/p-GSK3 signaling pathways and suppress CSC self-renewal capacity.
These results suggest that WPE has the potential to prevent and treat human
malignant colorectal cancer by regulating CSCs. In another study, it was found that
telomere length in WPE-treated cells were significantly decreased in a dose depen-
dent manner which could be a mechanistic link to the effect of walnuts on the
viability of colon CSCs. Telomere maintenance is a prerequisite for indefinite pro-
liferation in cancer. Therefore, inhibiting the maintenance of telomeres may prove
to be a useful strategy for cancer therapy [82]. Walnut consumption and the overall
health benefits are presented in Figure 3.
3.3 Pistachio
The Islamic Republic of Iran and United States of America are the world leaders
in pistachio production and cultivation followed by Turkey and China. Pistachio is
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known as the “green nut” and has been associated with human activities since
centuries [83]. Pistachios are good source of unsaturated fatty acids (linoleic acid,
linolenic acid, and oleic acid). They also contain a high amount of monounsaturated
fatty acids (MUFA) (>55%) [84]. Pistachios contain the highest levels of potassium,
g-tocopherol, vitamin K, phytosterols, folate, and xanthophyll carotenoids in com-
parison to other nuts. The diverse set up of nutrients makes pistachio a very good
health promoting food. The consumption of pistachio and relationship between
different disease conditions is presented in Table 8.
3.3.1 Pistachio and cardiovascular disease
Pistachios are rich source of numerous antioxidants, including tocopherols,
carotenes, lutein, selenium, flavonoids, and phytoestrogens. The high rate of
tocopherol in pistachio prevents heart disease, LDL oxidation, diabetes, and cancer
and promotes the immune system. Pistachios can enhance blood lipid profiles in
subjects with moderate hypercholesterolemia, and can in turn, reduce the risk of
Chronic Vascular Diseases [85]. The beneficial effect of pistachios on lipid profiles
may be due to essential fatty acids (EFAs) in its composition. In a study, when
pistachios were given to healthy young men for 4 weeks, significant decreases in
Figure 3.
Walnut consumption and health benefits.
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blood glucose, total cholesterol, and serum interleukin-6 were observed with
improved endothelium vasodilation and total antioxidant status [86]. The intake of
pistachios has been shown to significantly decrease oxidative stress as it contains the
highest amount of antioxidants. In another study, when twenty-eight hypercholes-
terolaemic adults were intervened with a diet containing 10 and 20% of energy
from pistachios (32–63 and 63–126 g/d, respectively) showed increased antioxidant
concentrations in serum, such as g-tocopherol, lutein and b-carotene, whereas it
decreased oxidized LDL concentrations comparison to a control diet without pista-
chios [87]. In 2007, Sheridan and colleagues [88] conducted a randomized cross
over trial where 15 patients with moderate hypercholesterolemia intervened with
4 weeks of dietary modification with 15% caloric intake (about 2–3 ounces per day),
from pistachio nuts. Results of the study showed significant changes in some blood
parameters such as 12% increase HDL-C and 9% decrease in TC/HDL-C, 14%
decrease in LDL-C/HDL-C, 13% decrease in B-100/A-1 and 9% decrease in LDL-C.
The results elucidate the effect of pistachio in reducing risk of coronary disease by
improvement of the lipid profiles. It has been reported that TC/HDL-C and LDL-
C/HDL-C are better predictors of CHD risk reduction than changes in levels [89].
London et al. [90] in a rat model found the health benefits of dietary pistachio in
terms of lowered total cholesterol, LDL-C fractions, a beneficial change in TC/HDL-
C and LDL-C/HDL-C. Regarding the ideal doses, 40 g or 1.5 oz./day of pistachio
intake found suitable for reduced fasting glucose and LDL-C concentrations and
increased HDL-C with improvements in vascular function in a clinical trial with
mild dyslipidemic adults [91]. The pistachio (42 and 84 g/day) nut intervention
during three weeks also lowered LDL-c concentrations (6%) in healthy volunteers
[92]. Pistachio is a magnesium rich nut (121 mg/100 g). Magnesium is associated
with lower the risk of abnormal cardiac excitation, atherosclerosis, ischemic heart
disease, and congestive heart failure [93]. Considering all these studies, the benefi-
cial effects of pistachios on lowering the risk of CVD could be through lipid-
lowering, imparting many antioxidant properties and magnesium content in it.
3.3.2 Pistachio and obesity
Obesity is associated with chronic low-grade inflammation which eventually
leads to abnormal metabolisms. A recent study conducted on mice demonstrated
that chronic intake of pistachio exerts beneficial effects in obese mice by alleviating
inflammation in adipose tissues and liver, and impacting the gut microbiome com-
position [94]. Nuts are very energy dense food item and there are reports of weight
gain with increased consumption of nuts without energy balance. However, the
daily ingestion of either 42 g or 70 g/day of pistachios for 12 weeks did not contrib-
ute to change in BMI or waist-to-hip ratio in Chinese subjects with metabolic
syndrome [95]. In a recent randomized controlled intervention, sixty healthy pre-
menopausal women in a group of 30 each consumed 44 g (250 kcal) pistachios
midmorning while controls (n = 30) maintained their current eating habits for
12 weeks. Pre- and post-intervention tests showed that ad libitum intake adjusted to
the pistachio portion, mostly via reduced intakes of carbohydrates and starch, in
parallel with decreased hunger and increased satiety following the morning snack. It
was concluded from the study that daily intake of 44 g pistachios improved nutrient
intake without affecting body weight or composition in healthy women. It was also
found that Intakes of MUFA, PUFA, linoleic acid, thiamin, pyridoxine, copper,
manganese, and zinc were significantly higher among women consuming the pista-
chio snack, in spite of compensatory adjustments in intake [96]. Similarly, in
another study, in healthy French women, in which a daily portion of pistachios was
compared to an isoenergetic load of a comparator food (cheese biscuits) ingested in
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the afternoon, reported no change in body weight after four weeks but it did
improve micronutrient intake [97]. It had also been seen that pistachio did not
contribute to weight gain in patients with obesity, prediabetic or diabetic conditions
[98–100]. It is suggested that the main mode of weight control of pistachio is
through increased satiation, satiety signals and lower metabolizable energy
[92, 101, 102].
3.3.3 Pistachio and diabetes
Studies have shown that pistachios promote a healthier metabolic profile by
lowering glucose level [92, 103]. Among all nuts, pistachios have a low glycemic
index. In a randomized cross-over study conducted on 20 subjects with the meta-
bolic syndrome, 85.04 g of pistachios consumed along with bread reduced post-
prandial glycaemia levels and increased glucagon-like peptide levels compared with
bread alone therefore, contribute to reducing the T2DM risk [104]. Jenkins et al.
[68] reported the reduction of HbA1c in T2DM subjects consumed mixed nuts
(including pistachios) for 3 months in a randomized controlled study as a replace-
ment for carbohydrate-containing foods compared with a half-nut and control-
muffin doses. In 2014, Gulati and colleagues [105] conducted a 24-wk randomized
control trial, 60 individuals with the metabolic syndrome were randomized to
either pistachio (20% energy) (intervention group) or control group. At the end of
the study, statistically significant improvement was seen in levels of fasting blood
sugar (FBG) however, no significant effect was seen on HbA1c and insulin levels. In
a recent study conducted to evaluate the acute effects of two isocaloric test meals,
42 g pistachios and 100 g whole-wheat bread (WWB) on postprandial glucose,
insulin, and gut derived incretin levels in Chinese women with gestational impaired
glucose tolerance (GIGT) or gestational diabetes mellitus (GDM) suggested that
pistachios are effective alternative to a low-fat, high-carbohydrate food to improve
postprandial glucose, insulin, and GLP-1 response in women with GDM and GIGT
[106]. The fiber, healthy fats, low available carbohydrate and carotenoid content
of pistachios are the important nutrients involved in glucose metabolism as
suggested by Bullo et al. [107]. Akbaraly et al. [108] reported that the higher
plasma carotenoid level was associated with 58% lower risk of T2DM mellitus.
Similarly, other phytonutrients in pistachios, such as ellagitannins, can also possibly
affect gastrointestinal sugar absorption and thus influence postprandial blood
glucose levels [109]. Pistachio consumption and effects on insulin resistance,
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3.3.4 Pistachio and cancer
Pistachios are rich sources of phenolic compounds such as epicatechin, querce-
tin, kaempferol, cyaniding-3-O-galactoside, cyanindin-3-O-glucoside, among other
polyphenol [110]. These poly phenolic compounds have strong antioxidant proper-
ties for which pistachio is ranked among 50 highest antioxidant food products [111].
Phenolic compounds play protective roles against free radical production and con-
trols disease like CVD and cancer. Seifaddinipour et al. [112] assessed the cytotoxic
effects of hexane, ethyl acetate, methanol, and water extract of pistachio hull
against human colon cancer (HT-29 and HCT-116), breast adenocarcinoma (MCF-
7), lung adenocarcinoma (H23), liver hepatocellular carcinoma (HepG2), cervical
cancer (Ca Ski), and normal fibroblast (BJ-5ta) cells using a MTT cell viability assay
and reported that pistachio hull extract has anti-tumor and anti-angiogenic poten-
tials. It is also suggested that the apoptosis induction and angiogenesis potential of
pistachio hull extract makes it a suitable product for further cancer research. In a
similar kind of study, pistachio extracts exhibited noteworthy cytotoxic potentials
against adenocarcinomic human alveolar basal epithelial cells (A-549), MCF-7, and
HeLa human cancer cells, compared to HUVEC control cells [113]. It is also
reported that the parts of pistachio known as waste parts such as hulls and oleo-gum
resins were found to possess higher cancer prevention potentials, compared to those
of the part consumed as food such kernels. The antioxidant properties of pistachio
on reduction of precancerous colon cancer lesion in rats were evaluated and it was
found that pistachio enhanced activities endogenous antioxidants such as
glutathione-s-transferase (GST), glutathione (GSH), glutathione peroxidase (GPx)
super oxide dismutase (SOD) and catalase. Glutathione is a very important non
enzymatic antioxidant which offers protection against reactive oxygen species
(ROS) as well as exogenous carcinogens [114]. This study also showed reduced
incidence of Aberrant Crypt Foci (ACF) and crypt multiplicity which are the earli-
est identifiable neoplastic lesions in the colon carcinogenetic model. There are
several studies on the anticancer properties of pistachio products and they all
indicate toward the presence of phytochemicals such as flavonoids, quercetin and
kaempferol and their antioxidant, antimicrobial, enzyme inhibitory and radical
scavenging effects to control cancer [115–117]. Pistachio consumption and the
overall health benefits are presented in Figure 4.
3.4 Cashew nuts
Cashew (Anacardium occidentale) is an evergreen tree native to Central and
South America. However, now a days, cultivated widely in Africa, India, Vietnam
and Sri Lanka. India is a major producer, processor, consumer and exporter of
cashew in the world. Nutritional composition of cashew nuts includes good quantity
of MUFA, squalenes, phytosterols, β-carotene, lutein, zeaxanthin, α-tocopherol, γ-
tocopherol and thiamin [24, 118]. Cashews nut is also very good source of copper
and zinc. The consumption of cashew nut and relationship between different dis-
ease conditions is presented in Table 9.
3.4.1 Cashew nut and cardiovascular disease
The micronutrients such as folate and tocopherols what found in cashew nut are
very important in terms of protecting against atherosclerosis and other chronic non-
communicable diseases (CNCD) [119]. Various epidemiological studies have drawn
a link between folate status and atherosclerotic vascular disease. The relationship
between low serum folate levels and increased cardiovascular disease risk has also
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been seen in many studies [120, 121]. Dietary factors such as single high fat meal,
oral fat load, animal protein and less fruit and vegetable consumption causes tem-
porary endothelial dysfunction and increases cardiovascular disease risk [122, 123].
Reports claim that the supplementation of folic acid completely prevented the
observed diet-induced impairment in endothelial function [124]. The mechanistic
principle behind the action of folic acid is that, it reduces the plasma homocysteine
levels which happen to be a causal factor in cardiovascular disease [125]. Tocoph-
erols are strong antioxidants which exert cardiovascular (CV) benefit, including
inhibition of oxidation of low-density lipoprotein (LDL) cholesterol in plasma
[126]. Cashew nuts because of their high saturated fat content were exempted from
“heart healthy” health claim by Federal Drug Administration in the year 2003.
However, many recent studies claim the ability of cashew nuts to lower total and
LDL-C [127]. In 2018, a 12-week randomized controlled study conducted by Mohan
V and colleagues [128] reported that cashew nut supplementation reduced systolic
blood pressure and increased HDL-C in Asian Indians with type-2 diabetes mellitus
with no deleterious effects on body weight, glycemia, or other lipid variables.
Figure 4.
Pistachio consumption and health benefits.
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According to the authors the MUFA content of cashew nut increased the level of
apolipoprotein A-I (apoA-I) which is capable to increase the endogenous synthesis
of functional HDL particles. However, the meta-analysis data of Mahboobi [129]
showed that cashew can improve triglyceride levels as well as maintain systolic and
diastolic blood pressure with no significant effects on other cardiometabolic factors
such as total cholesterol, HDL-C, and LDL-C.
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Table 9.
Effect of Cashew nut consumption on different disease conditions.
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3.4.2 Cashew nut and obesity
Cashew nuts are rich in energy and dietary fiber which exerts beneficial effect
on weight management. Dietary fiber can produce a feeling of fullness in the
stomach, controls appetite suggested as an aid in weight loss diets. A study
conducted by Asdaq and Malsawmtluangi [130] on the anti-obesity effect of cashew
nut in rats fed on cafeteria and atherogenic diet reported that cashew high dose
(200 mg/kg) is effective in decreasing body weight, lipid parameters like LDL,
VLDL, TG, TC and increased HDL level. They also observed from the study that
there was decreased fat-pad weights like Kidney fat, Mesenteric fat, and Uterine fat
which showed the anti-obesity potential of cashew nut. The authors suggested the
anti-obesity activity of cashew nut might be due to the presence of soluble fibers
and flavonoids, namely, catechin, epicatechin, and epigallocatechin, which inhibit
lipoxygenase. In another study, Beejmohun et al. [131] evaluated the effect of
cashew nut apple extract on obesity and diabetes using the diet-induced obesity
(DIO) mouse model. Two different designs: a ‘prevention’ design and curative
design was adopted to evaluate the ability of the extract to prevent the development
of obesity, hyperglycaemia and insulin resistance, and capacity to reverse an
established disease state, respectively. In both the designs, cashew apple extract of
200 mg/kg body weight significantly reduced body-weight gain, fat storage,
hyperglycaemia, hyperinsulinaemia and insulin resistance in DIO mice. It was
suggested from the study that reduction in body-weight gain was at least partly due
to a decrease in the peri-epididymal (perivisceral) adipose tissue mass. It has been
seen that cashew nut supplementation in Asian Indians with type-2 diabetes had no
deleterious effects on body weight [128].
3.4.3 Cashew nut and diabetes
An eight-week, randomized, isocaloric, controlled-feeding study was conducted
by Darvish Damavandi et al. [132] on 50 patients with type 2 diabetes mellitus
(T2DM) randomly assigned to either the control or intervention group with 10% of
total calorie from cashews. The results demonstrated that replacing 10% of daily
total energy intake with unsalted cashews reduced serum insulin and LDL-C/HDL-
C ratio (as an atherogenic index) in patients with T2D. Authors suggested that the
decrease could be due to the bioactive compounds, as well as unsaturated fatty acids
(MUFAs and PUFAs) present in cashews, which may play an important role in
insulin and lipid profile control. Also, fiber and polyphenols may have anti-diabetic
effects by regulating microbiome and lipid profile ratio. In an animal model study,
the cashew plant bark extract showed a potential antidiabetic activity. Methanol
extract of cashew plant stem-bark at a dose of 200.0 mg/kg body weight improved
plasma glucose and lipids in fructose-induced diabetic rats, which was associated
with a reduced lipid peroxidation [133]. Viguiliouk et al. [10] through a meta-
analysis reported that diet supplemented with tree nuts (almonds, Brazil nuts,
cashews, hazelnuts, macadamia nuts, pecans, pine nuts, pistachios and walnuts) at a
median dose of 56 g/day improved glycemic control in subjects with T2DM, show-
ing significantly decreased HbA1c levels and fasting glucose with no effect on
fasting insulin or homeostasis model assessment of insulin resistance index
(HOMA-IR).
3.4.4 Cashew nut and cancer
The cashew nuts contain phenolic compounds which are strong antioxidants and
capable of scavenging free super oxide radicals, reducing the risk of cancer [134].
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However, there are many reports on the use of cashew nut shell liquid (CNSL) from
cashew nut as a potent anti- cancer agent. Anacardic acids are the main constituents
of natural CNSL. In a study, 50 mg/kg of anacardic acids ameliorated tumor necro-
sis factor in lungs induced by exposure to diesel exhaust particles in mice [135].
Anacardic acid was the first natural product inhibitor of histone acetyltransferase
(HAT) activities reported [136]. HATs are the critical regulators of cell develop-
ment and carcinogenesis [137]. It is also reported that anacardic acid presents anti-
inflammatory and anti-invasive properties by suppressing tumor necrosis factor
(TNF)-α-induced overexpression of anti-apoptotic proteins (e.g., Bcl-2, Bcl-xl, and
survivin) and UV-induced tumorigenesis [138, 139]. In a study conducted by Ashraf
and Rathinasamy [140] to check the antibacterial and anticancer activity of the
purified CNSL, it inhibited the proliferation of HeLa cells with an IC50 of 0.004%
(v/v) and inhibited the growth of Bacillus subtilis with an IC50 of 0.35% (v/v). It
induced apoptosis in HeLa cells and accelerated wound closure in L929 cells.
Authors concluded that CNSL have the potential to be used as anticancer and
antibacterial drug development. These data suggests the anticancer role of
anacardic acid. Anacardic acids (AAs) are alkyl phenols. Higher amounts of AAs
have been detected in CNSL (353.6 g/kg) followed by cashew fiber (6.1 g/kg), while
the lowest (0.65 g/kg) amounts were found in roasted cashew nut [141]. Cashew
nut consumption and the overall health benefits are presented in Figure 5.
3.5 Other nuts
The tree nuts such as Brazil nut, hazel nut, macadamia nut, pine nut, pecans and
legume, pea nut possess good quantity of protein, unsaturated fatty acids, dietary fibers,
vitamins, minerals and different bioactive compounds, such as phytosterols, phenolic
Figure 5.
Cashew nut consumption and health benefits.
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compounds and carotenoids. These compounds are able to reduce cholesterol levels and
promote antioxidant and anti-inflammatory effects. The consumption of some other
nuts and relationship between different disease conditions is presented inTable 10.
3.5.1 Cardiovascular diseases
In a study, it was observed that 9 hours after the ingestion of 20 or 50 g of Brazil
nut serum LDL-c level significantly reduced and HDL-c significantly improved.
Interestingly, significant increase of the plasma selenium levels was observed at
6 hours within the groups receiving the nuts [142]. It was suggested from the study
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that the change in lipid level could be due to the presence of selenium which
mediates selenoproteins. Some selenoproteins such as glutathione peroxidase (GPx)
and thioredoxinreductase (TrxR) are important antioxidant enzymes and can pro-
vide cardiovascular benefits [143]. Similarly, it was observed that hazelnut-
enriched diets exerted antiatherogenic effect by improving endothelial function,
preventing LDL oxidation, and inflammatory markers beyond only lipid lowering
effect [144]. However, after 4 weeks on a hazel nut free diet, the beneficial effects
got changed. Hazel nut is a good source of vitamin E, which protects low-density
lipoprotein (LDL) against oxidation and a high level of L-arginine, which is precur-
sor of nitric oxide and other bioactives, could be the reason of antiatherogenic
effect. It is suggested from the study that hazelnut may be incorporated into daily
diet without change in total caloric intake for sustained health benefit. It has also
been seen in women with type 2 diabetes that frequent nut and peanut butter
consumption (serving size, 28 g (1 ounce) for nuts and 16 g (1 tablespoon) for pea
nut butter) was associated with a significantly lower CVD risk [145]. Macadamia
nuts are good source of MUFA and have been tried in the diets to reduce the TC and
LDL-cholesterol with positive results [146, 147]. Improvements of vascular func-
tion reduce CVD risk. It is indicated from many epidemiological studies that nuts
have positive effects on vascular endothelial function [148, 149].
3.5.2 Obesity
Obesity is one of the reasons of morpho-functional microvascular damage. The
intake of 15–25 g/day Brazil nuts improved the microvascular function in obese
female adolescents BMI of 35.6  3.3 kg/m2. It is suggested that the bioactive
substances of Brazil nut like selenium, α- e γ- tocopherol, folate and polyunsatu-
rated fatty acids improved the microcirculation with their antioxidant capacity
[150]. It is also observed that a high intake of Se from Brazil nut for long periods by
obese women was harmful to health which was associated with the gene expression
of some inflammatory markers [151]. The tolerable upper intake level (UL) of Se is
around 400 mg/day, for both males and females [152] could be the reason with high
intake of Brazil nut and associated health problems. Experimental evidences suggest
that consumption of hazel nut up to 60 g per day did not affect weight and improve
blood cholesterol levels [153]. Renzo et al. [154] observed that when 24 healthy
volunteers consumed 40 g of hazelnuts (261.99 kcal/1096.17 kJ) daily as a snack for
six weeks, did not gain weight but a significant up regulation was detected for
SOD1, CAT, macrophage migration inhibitory factor (MIF), PPARγ, vitamin D
receptor (VDR), methyl enetetra hydrofolate reductase (MTHFR) and angiotensin
I-converting enzyme (ACE) which was an indication of modulation in oxidative
stress and inflammation gene expression. Alper and Mattes [155] reported that
peanut consumption has little effect on energy balance when peanuts are added to,
or incorporated into, an energy-controlled diet. Little change in body weight over
3 weeks with peanuts added to habitual diets. In a study when obese mice were
supplemented with macadamia nut oil, hypertrophy of adipocytes, inflammation in
the adipose tissue and macrophages were attenuated [156]. It is suggested from the
study that the reduced/controlled growth of adipocytes brings more cellular
homeostasis and decreases leptin production and secretion. Otherwise, leptin is
associated with an elevation in low grade inflammation.
3.5.3 Diabetes
Diabetes elicits oxidative stress and causes DNA damage. Prevention of DNA
oxidation is extremely important and through dietary interventions, T2D-related
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complications and DNA damage can be prevented. In this regard, Mecan et al. [157]
investigated the correlation of Brazil nut supplementation and DNA damage in T2D
patients and found significant increase in fasting blood glucose after six months of
consuming Brazil nuts; however, no significant effect was observed on the levels of
HbA1c level. The cells were more resistant to H2O2-induced DNA damage after six
months of supplementation with Brazil nut. It was concluded from the study that
consumption of Brazil nuts could decrease oxidative DNA damage in T2D patients,
probably through the antioxidative effects of Se. An 8-week controlled randomized
parallel study in patients with T2D indicated that incorporation of hazelnuts into
diet (10% of total daily calorie intake was replaced with hazelnuts) in intervention
group can prevent reduction of HDL-C concentrations in patients with type 2
diabetes, but had no effect on FBS or other lipid profile indices [158]. However, it is
suggested from the studies that the Mediterranean-style diet with 30 g of mixed
nuts (15 g/d walnuts, 7.5 g/d hazelnuts and 7.5 g/d almonds) could improve FBS
concentration after 3 months in patients at high-risk for CVD [159]. In contrast,
Casas-Agustench et al. [160] demonstrated that incorporating 30 g of mixed nuts
(15 g/d walnuts, 7.5 g/d hazelnuts, and 7.5 g/d almonds) into a healthy diet for
12 weeks did not affect FBS. Study conducted by Jiang et al. [161] very elaborately
discussed about the nut and pea nut butter consumption on the diabetes outcomes.
The authors reported that nut and peanut butter consumption was inversely asso-
ciated with risk of type 2 diabetes. Diabetes reduced 27% in those who ate nuts 5 or
more times per week compared with those who rarely or never ate nuts.
3.5.4 Cancer
Ip and Lisk [162] reported the relationship between Brazil nut and prevention of
mammary cancer. They compared the selenium in Brazil nut with selenite selenium
and found both were equally bioactive. Their study demonstrated a dose-dependent
inhibitory response at dietary Se concentrations of 1–3 mg/g in dimethylbenz[a]
anthracene-treated rat model. The anti-carcinogenic activity of Se has also been
tried in other animal models with positive response. Selenium is an important
component of antioxidant enzymes and the beneficial effects in terms of inhibition
of cell proliferation, triggering apoptosis and repairing DNA activating p53 is
mainly because of the antioxidant properties [163]. Antimutagenecity and antican-
cer activities has also been reported from fresh hazelnuts whereas dried hazelnut
shows moderate activity [164]. Hazenut shell extract contains phenolic compounds,
including neolignans, and a diarylheptanoid which has strong antioxidant proper-
ties. It is a potent anticancer agent and showed an inhibitory effect on the growth of
human cancer cell lines A375, SK-Mel-28 and HeLa [165]. Macadamia nut is a good
source of tocopherols, tocotrienols, and squalene which can confer antioxidant and
anticancer properties to consumers. Nieuwenhuisa and Brandt [166] conducted a
large prospective cohort study and reported that total nut, tree nut, and peanut
intake reduced the risk of small cell carcinoma in men.
4. Conclusion
All nuts contain good quantity of MUFAs, PUFAs, fibers, vitamins, minerals and
bioactive compounds with antioxidant potential which makes them a good candi-
date in human diets. Almond consumption reduces serum triglyceride, total choles-
terol and LDL-C in the subjects mainly due to the presence of vitamin E and
phenolic compounds in it. Similarly, almond consumption also helps in weight loss,
lowered glycosylated hemoglobin, and reduced blood glucose when tried in patients
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with obesity and diabetes. The benefit of almond for cancer prevention is mainly
due to the phytochemicals such as quercentin and kampferol which is known for
reducing prostrate and lungs cancer cell growth. Walnut consumption is also very
useful for reducing cardiovascular disease risk. Walnut intake not only improves
blood lipid profile by reducing triglyceride and total cholesterol but also improves
flow mediated dialation, HDL-C level and apolipoproten B status which is very
useful for heart health. Despite an energy dese nut, walnut did not contribute to
weight gain in any of the trials with obese patients but helped in controlling systolic
blood pressure. In diabetic patients walnut intake reduces fasting blood sugar and
HBA1C. Walnut contains tocopherol, βsitosterol, and peduncalgin which have anti-
cancer properties. In human cell line studies for role of walnut in cancer prevention
found walnut oil is capable of inducing necrosis and down regulated NFkB. Pista-
chio intake increases serum antioxidants and reduces oxidized LDL-C through
which imparted beneficial effect on cardiovascular health status. It also controls
obesity and diabetes through increasing satiation and regulating glucose metabo-
lism. The hull extract of pistachio shows anticancer properties and radical scaveng-
ing activities. Almond, walnut and pistachio consumption in a range of 42 to 85 g/
day was found to be beneficial for human health. Cashew nut is very common and
popular among nuts. The intake of 30 g/day cashew nut is beneficial for heart health
and also does not contribute to weight gain. In an animal model study, the cashew
plant bark extract showed a potential antidiabetic activity. Cashew nut shell liquid
(CNSL) from cashew nut is a potent anti- cancer agent. The phenolic compounds
present in cashew nut are also strong antioxidants and capable of scavenging free
super oxide radicals, reducing the risk of cancer. Similarly, intake of Brazil nut and
hazel nut in a range of 25–50 g/day imparted beneficial effects on antioxidant status
and reduced risk of diabetes and cancer. Moreover, daily nut intake of tree nut or
pea nut has demonstrated an active role in controlling inflammation, dyslipidemia
and oxidative stress.
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